Second Opinion Providers

 

Healthcare investment “through the bottom of the cycle” — Goldberg (Rothschild)

At last year’s conference Hedley Goldberg, Managing Director at multinational investment bank Rothschild, predicted healthcare M&A activity would begin picking up again in Q4 2023 or Q1 2024. But we’re now halfway through 2024 and there are still very few deals above €500m taking place. Goldberg is confident, however, that we have now passed through the bottom of the cycle.

Deploying new generation apps – 6 things health care operators must get right, and the 13 mistakes they often make

New tech promises to allow humans AI-driven health care conversations over text, voice, and email, leading to real dialogue and much more intelligent monitoring. Some of this stuff is here now.  Here are the six main cornerstones health care operators should know when deploying it, and the 13 big mistakes that affect health care operators when they try and do tech stuff.

FREE BLOG New HBI pipeline tool reveals long-held investments 

Nearly a third of all private equity-owned health care businesses in Europe have been held for at least five years, according to the new HBI Deals Pipeline tool. That suggests many private equity houses are struggling to sell on their investments.

Interview with WebMD: We have no plans to become a diagnostics tool

WebMD, the world's largest health information website, just got even larger with the acquisition of its close rival Aptus Health. HBI speaks to Jeremy Schneider, the company's group general manager, about whether the platform could ever become a healthcare provider, the acquisition and its ambitions outside of the US. 

FREE BLOG HBI Awards 2018: Measuring fat and muscle more accurately with MRI scans

The medical community relies on the notoriously inaccurate Body Mass Index (BMI) measurement when it comes to measuring body fat. AMRA has developed a way of producing 3D-volumetric fat and muscle measurements using a single six-minute MRI scan which is far more accurate. This will enable doctors to better identify at risk patients such as those with high fat levels in the abdomen – visceral fat. Elderly patients with muscle loss and increased fat, a debilitating condition known as sarcopenia, can also be identified. AMRA has introduced a new paradigm where rapid, 6-minute whole body MRI scans are analysed to produce precise, three – dimensional volumetric fat and muscle measurements. This standardized, automated method eliminates reader variability and reduces processing costs. AMRA also researches the relationships between fat, muscle and the development of disease, with the aim to become the new global standard in body composition. AMRA’s aim is also to support the precise tracking of treatment effects, the identification of who should participate in clinical trials, and the understanding of those who are at risk of developing disease.

Are you ready for GDPR?

The clock is ticking for businesses to comply with the General Data Protection Regulation, which comes into force on May 25. Healthcare Europa talks to Aetna International's CIO Alan Payne to find out what the data handling regulations mean for healthcare insurers and operators, and the challenges on the path to compliance.

Find Us